Clinical Trials Browser

Endometrial Hyperplasia, Neoplasms, Obesity, Endometrial Neoplasms, Overweight

NCT07513259 2026-04-07

Pre-Diagnosis GLP-1 Receptor Agonist Use and Post-Cancer Mortality in Adults With Obesity and Type 2 Diabetes

Completed

203,424 enrolled

Other

Diabetes Mellitus, Type 2, Neoplasms, Obesity, Overweight

NCT06205251 2026-03-30

Diaphragm Structure and Function in Childhood Cancer Survivors

Phase NA Completed

7 enrolled

Other

Dyspnea, Neoplasms

NCT06848491 2026-03-23

AYAWell

Phase NA Recruiting

240 enrolled

Other

Motor Activity, Neoplasms, Obesity

NCT02173756 2026-03-16

MorphinOgel

Phase 3 Terminated

25 enrolled

Other

Neoplasms, Mucositis

NCT07447440 2026-03-11

RESOLBE

Recruiting

60 enrolled

BreastOther

Breast Neoplasms, Neoplasms, Obesity

NCT06184256 2026-02-27

BfedBwell Optimization Pilot

Phase NA Recruiting

74 enrolled

Other

Motor Activity, Neoplasms, Obesity, Overweight

NCT07412782 2026-02-17

REMS25: Study on the Use of REMS Technology in Diseases Commonly Associated With Reduced Bone Mineral Density (BMD)

Phase NA Recruiting

100 enrolled

EndocrineOther

Bone Diseases, Metabolic, Cushing Syndrome, Dwarfism, Pituitary, Neoplasms, Obesity, Osteogenesis Imperfecta, Osteoporosis, Malnutrition, Overweight

NCT05561595 2026-02-05

HEARTS

Phase NA Recruiting

195 enrolled

Other

Diabetes Mellitus, Neoplasms, Obesity, Skin Diseases, Chronic Pain

Clinical Trials

SHAPE-ENDO

Pre-Diagnosis GLP-1 Receptor Agonist Use and Post-Cancer Mortality in Adults With Obesity and Type 2 Diabetes

Diaphragm Structure and Function in Childhood Cancer Survivors

AYAWell

MorphinOgel

RESOLBE

BfedBwell Optimization Pilot

REMS25: Study on the Use of REMS Technology in Diseases Commonly Associated With Reduced Bone Mineral Density (BMD)

HEARTS